Xiangping Li
Impact in
- Cancer Research top 1%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Molecular Biology top 5%
- Circular RNAs in diseases
- RNA modifications and cancer
- CRISPR and Genetic Engineering
- Epigenetics and DNA Methylation
- RNA Interference and Gene Delivery
Papers in
-
- Cancer-related molecular mechanisms research 23
- MicroRNA in disease regulation 13
-
- Gastroesophageal reflux and treatments 8
Xiangping Li
98 papers receiving 3.8k citations
Hit Papers
Peers
Comparison fields: 5 of 132
- Cancer Research 1.3k
- Molecular Biology 2.4k
- Immunology 622
- Obstetrics and Gynecology 201
- Genetics 549
Countries citing papers authored by Xiangping Li
This map shows the geographic impact of Xiangping Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangping Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangping Li more than expected).
Fields of papers citing papers by Xiangping Li
This network shows the impact of papers produced by Xiangping Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangping Li. The network helps show where Xiangping Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiangping Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 3 | |
| 3 | 2024 | 10 | |
| 4 | 2024 | 5 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 1 | |
| 7 | 2022 | 0 | |
| 8 | 2022 | 1 | |
| 9 | 2021 | 17 | |
| 10 | 2020 | 2 | |
| 11 | 2018 | 176 | |
| 12 | 2017 | 70 | |
| 13 | 2016 | 1 | |
| 14 | 2013 | 91 | |
| 15 | 2013 | 86 | |
| 16 | 2012 | 6 | |
| 17 | 2011 | 328 | |
| 18 | 2010 | 51 | |
| 19 | 2006 | 20 | |
| 20 | 1995 | 19 |
About Xiangping Li
Xiangping Li is a scholar working on Cancer Research, Gastroenterology, Otorhinolaryngology, Oncology and Immunology, having authored 104 papers that have together received 3.8k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (23 papers), MicroRNA in disease regulation (13 papers), RNA modifications and cancer (12 papers), Viral-associated cancers and disorders (11 papers), Circular RNAs in diseases (8 papers), Immune Cell Function and Interaction (8 papers), Gastroesophageal reflux and treatments (8 papers) and Virus-based gene therapy research (7 papers). The work is most often cited by research in Cancer Research (1.3k citations), Molecular Biology (2.4k citations), Immunology (622 citations), Obstetrics and Gynecology (201 citations) and Genetics (549 citations). Xiangping Li has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Juan Lü, Xiong Liu, John McCoy, Xinhua Lee, Sha Mi, Edward R. LaVallie, James C. Keith, Geertruida M. Veldman, Heather Finnerty and Hsiang‐Fu Kung. Their work appears in journals such as Acta Oto-Laryngologica, Oncotarget, Diabetes, Cancer Letters and Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.